Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
Sponsor: Hvidovre University Hospital
Summary
Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.
Official title: The Effect of ASTARTE™; Lactobacillus Crispatus, Lactobacillus Rhamnosus, Lactobacillus Jenesii and Lactobacillus Gasseri on the Reduction of Risk Factors for Recurrent Urinary Tract Infection in Women
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
720
Start Date
2022-09-19
Completion Date
2027-12-01
Last Updated
2022-09-23
Healthy Volunteers
Yes
Conditions
Interventions
ASTARTE™ oral capsules
1 Capsule daily for 6 months
Placebo oral capsules
1 Capsule daily for 6 months
Locations (1)
Gastrounit, Copenhagen University Hospital Hvidovre
Hvidovre, Copenhagen, Denmark